• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血糖正常和高血糖患者个体血浆蛋白的非酶糖基化

Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients.

作者信息

Austin G E, Mullins R H, Morin L G

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322.

出版信息

Clin Chem. 1987 Dec;33(12):2220-4.

PMID:3690840
Abstract

Diabetic patients in poor glycemic control show increased glycation of total plasma proteins, but little is yet known about the relative extents to which the various individual proteins are glycated. Thus, we studied the non-enzymic glycation of several major plasma proteins and plasma protein fractions in normal and diabetic patients. In vivo glycation for most plasma proteins was very low in non-diabetic patients, only gamma globulin showing more than 5% glycation. In diabetic plasmas, glycation was much greater, immunoglobulins again showing the greatest proportion, followed in descending order by albumin, complement C3, fibrinogen, transferrin, haptoglobin, and alpha-1-antitrypsin. When plasma proteins were glycated in vitro, this order was IgG greater than complement C3 greater than albumin greater than transferrin greater than haptoglobin greater than alpha-1-antitrypsin. In general, proteins with the longest biological half-lives, such as IgG and albumin, showed the greatest in vivo glycation. On the other hand, proteins with high intrinsic glycability, such as complement C3, showed moderate glycation, despite a short half-life. Except for albumin, more basic proteins showed greater glycation than acidic proteins, but there was poor correlation between mole percent lysine and glycation. Evidently the relative extents of glycation of different plasma proteins are a complex function of integrated glucose concentrations over time and of the half-life and chemical characteristics of each protein.

摘要

血糖控制不佳的糖尿病患者血浆总蛋白的糖化作用增强,但对于各种单个蛋白糖化的相对程度,目前了解甚少。因此,我们研究了正常人和糖尿病患者几种主要血浆蛋白及血浆蛋白组分的非酶糖化作用。在非糖尿病患者中,大多数血浆蛋白的体内糖化作用非常低,只有γ球蛋白的糖化率超过5%。在糖尿病患者的血浆中,糖化作用要强得多,免疫球蛋白的糖化比例再次最高,其次依次是白蛋白、补体C3、纤维蛋白原、转铁蛋白、触珠蛋白和α-1抗胰蛋白酶。当血浆蛋白在体外进行糖化时,顺序为IgG>补体C3>白蛋白>转铁蛋白>触珠蛋白>α-1抗胰蛋白酶。一般来说,生物半衰期最长的蛋白,如IgG和白蛋白,体内糖化作用最强。另一方面,内在糖化能力高的蛋白,如补体C3,尽管半衰期短,但糖化作用中等。除白蛋白外,碱性较强的蛋白比酸性蛋白的糖化作用更强,但赖氨酸摩尔百分比与糖化作用之间的相关性较差。显然,不同血浆蛋白糖化的相对程度是葡萄糖浓度随时间综合作用以及每种蛋白半衰期和化学特性的复杂函数。

相似文献

1
Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients.血糖正常和高血糖患者个体血浆蛋白的非酶糖基化
Clin Chem. 1987 Dec;33(12):2220-4.
2
On glucose transport and non-enzymic glycation of proteins in vivo.关于体内葡萄糖转运及蛋白质的非酶糖基化作用
J Theor Biol. 1993 Apr 21;161(4):481-90. doi: 10.1006/jtbi.1993.1068.
3
Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.2型糖尿病中阿马多里修饰血浆蛋白的鉴定及短期强化胰岛素治疗的效果
Diabetes Care. 2005 Mar;28(3):645-52. doi: 10.2337/diacare.28.3.645.
4
Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site.载脂蛋白E的糖基化会损害其与肝素的结合:主要糖基化位点的鉴定。
Biochim Biophys Acta. 1999 Aug 30;1454(3):296-308. doi: 10.1016/s0925-4439(99)00047-2.
5
Kinetic analysis of glycation as a tool for assessing the half-life of proteins.糖化反应的动力学分析作为评估蛋白质半衰期的一种工具。
Biochim Biophys Acta. 1986 Oct 29;884(1):199-205. doi: 10.1016/0304-4165(86)90244-8.
6
Postmortem diagnosis of diabetic metabolic derangement: elevated alpha 1-antitrypsin and haptoglobin glycosylation levels as an index of antemortem hyperglycemia.
J Forensic Sci. 1996 Jan;41(1):94-100.
7
Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus.2型糖尿病患者的高血糖状况对人血浆蛋白的糖基化位点有不同程度的影响。
Anal Bioanal Chem. 2014 Sep;406(24):5755-63. doi: 10.1007/s00216-014-8018-y. Epub 2014 Jul 30.
8
Multiple Glycation Sites in Blood Plasma Proteins as an Integrated Biomarker of Type 2 Diabetes Mellitus.血浆蛋白质中的多个糖基化位点作为 2 型糖尿病的综合生物标志物。
Int J Mol Sci. 2019 May 10;20(9):2329. doi: 10.3390/ijms20092329.
9
Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers.糖基化作用会增加蛋白质透过血神经屏障和血脑屏障的通透性。
Brain Res Mol Brain Res. 1994 Apr;23(1-2):157-62. doi: 10.1016/0169-328x(94)90222-4.
10
Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study.高血糖诱导糖尿病患者人血清白蛋白的结构和功能变化:一项物理化学研究。
Mol Biosyst. 2016 Jul 19;12(8):2481-9. doi: 10.1039/c6mb00324a.

引用本文的文献

1
A Transcriptome Array-Based Approach to Link SGLT-2 and Intrarenal Complement C5 Synthesis in Diabetic Nephropathy.基于转录组芯片的方法探讨糖尿病肾病中 SGLT-2 和肾内补体 C5 合成的关系。
Int J Mol Sci. 2023 Dec 2;24(23):17066. doi: 10.3390/ijms242317066.
2
Effect of Iron Deficiency Anemia on Glycated Albumin Levels: A Comparative Study in Nondiabetic Subjects with Iron Deficiency Anemia.缺铁性贫血对糖化白蛋白水平的影响:缺铁性贫血非糖尿病患者的一项对比研究
J Lab Physicians. 2022 Oct 20;15(2):253-258. doi: 10.1055/s-0042-1757589. eCollection 2023 Jun.
3
Effect of transferrin glycation induced by high glucose on HK-2 cells .
高糖诱导转铁蛋白糖基化对 HK-2 细胞的影响。
Front Endocrinol (Lausanne). 2023 Jan 26;13:1009507. doi: 10.3389/fendo.2022.1009507. eCollection 2022.
4
Metabolic labeling unveils alterations in the turnover of HDL-associated proteins during diabetes progression in mice.代谢标记揭示了在小鼠糖尿病进展过程中 HDL 相关蛋白周转率的变化。
Am J Physiol Endocrinol Metab. 2022 Dec 1;323(6):E480-E491. doi: 10.1152/ajpendo.00158.2022. Epub 2022 Oct 12.
5
The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.美国儿童和青少年中糖化白蛋白作为血糖水平和心代谢风险生物标志物的表现。
Pediatr Diabetes. 2022 Mar;23(2):237-247. doi: 10.1111/pedi.13281. Epub 2021 Dec 26.
6
Comprehensive overview of human serum albumin glycation in diabetes mellitus.糖尿病患者血清白蛋白糖基化的综合概述
World J Diabetes. 2021 Jul 15;12(7):1057-1069. doi: 10.4239/wjd.v12.i7.1057.
7
Non-Enzymatic Glycation of Transferrin and Diabetes Mellitus.转铁蛋白的非酶糖基化与糖尿病
Diabetes Metab Syndr Obes. 2021 Jun 8;14:2539-2548. doi: 10.2147/DMSO.S304796. eCollection 2021.
8
Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus.α-1抗胰蛋白酶在1型和2型糖尿病中的治疗潜力
Medicina (Kaunas). 2021 Apr 20;57(4):397. doi: 10.3390/medicina57040397.
9
Complement, a Therapeutic Target in Diabetic Kidney Disease.补体,糖尿病肾病的一个治疗靶点。
Front Med (Lausanne). 2021 Jan 21;7:599236. doi: 10.3389/fmed.2020.599236. eCollection 2020.
10
Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes.内脏脂肪过多与2型糖尿病患者糖化白蛋白和糖化血红蛋白之间的差异有关。
Diabetol Int. 2020 Mar 21;11(4):368-375. doi: 10.1007/s13340-020-00431-z. eCollection 2020 Oct.